Literature DB >> 2795758

Hyperprolactinemia and impotence: why, when and how to investigate.

M P Leonard1, C J Nickel, A Morales.   

Abstract

The contribution of hyperprolactinemia to erectile disorders has not been clarified. Modest elevations of serum prolactin occur after administration of drugs that by themselves affect erectile function. Prolactinomas produce marked elevations of the hormone and invariably are accompanied by hypogonadotropic hypogonadism. Among 1,236 consecutive impotent patients investigated at our center 5.3% had serum levels of prolactin greater than normal. Only 34 of the 66 hyperprolactinemic patients were available for analysis. The etiology of the hyperprolactinemia in this group was pituitary adenoma in 14.7%, drug-induced in 29%, chronic renal failure in 6%, laboratory error in 2.9% and idiopathic in 47.1%. Medical management has a high degree of success but simply lowering the levels of prolactin is not invariably accompanied by restoration of function.

Entities:  

Mesh:

Year:  1989        PMID: 2795758     DOI: 10.1016/s0022-5347(17)38964-4

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  10 in total

Review 1.  Drugs for the treatment of impotence.

Authors:  L Garcia-Reboll; J P Mulhall; I Goldstein
Journal:  Drugs Aging       Date:  1997-08       Impact factor: 3.923

Review 2.  Physiology of penile erection and pathophysiology of erectile dysfunction.

Authors:  Robert C Dean; Tom F Lue
Journal:  Urol Clin North Am       Date:  2005-11       Impact factor: 2.241

Review 3.  PRL secreting adenomas in male patients.

Authors:  Antonio Ciccarelli; Ermelinda Guerra; Michele De Rosa; Francesco Milone; Stefano Zarrilli; Gaetano Lombardi; Annamaria Colao
Journal:  Pituitary       Date:  2005       Impact factor: 4.107

4.  Comparison of Male and Female Prolactinoma Patients Requiring Surgical Intervention.

Authors:  Frederick Yoo; Carmen Chan; Edward C Kuan; Marvin Bergsneider; Marilene B Wang
Journal:  J Neurol Surg B Skull Base       Date:  2017-12-26

Review 5.  Impotence in elderly men.

Authors:  J E Morley; F E Kaiser
Journal:  Drugs Aging       Date:  1992 Jul-Aug       Impact factor: 3.923

6.  Routine prolactin measurement is not necessary in the initial evaluation of male impotence.

Authors:  B E Akpunonu; A B Mutgi; D J Federman; J York; L S Woldenberg
Journal:  J Gen Intern Med       Date:  1994-06       Impact factor: 5.128

7.  Effect of blood sampling on apomorphine-induced penile tumescence in erectile impotence: a case report.

Authors:  M E Kiely; J X Thavundayil; S Lal
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186

Review 8.  Is Adjunct Aripiprazole Effective in Treating Hyperprolactinemia Induced by Psychotropic Medication? A Narrative Review.

Authors:  Frank M C Besag; Michael J Vasey; Iffah Salim
Journal:  CNS Drugs       Date:  2021-04-20       Impact factor: 5.749

9.  The Effect of Alcohol Administration on the Corpus Cavernosum.

Authors:  See Min Choi; Deok Ha Seo; Sin Woo Lee; Chunwoo Lee; Seong Uk Jeh; Sung Chul Kam; Jeong Seok Hwa; Ky Hyun Chung; Jae Seog Hyun
Journal:  World J Mens Health       Date:  2016-12-22       Impact factor: 5.400

10.  Adjunctive Aripiprazole Treatment for Risperidone-Induced Hyperprolactinemia: An 8-Week Randomized, Open-Label, Comparative Clinical Trial.

Authors:  Jingyuan Zhao; Xueqin Song; Xiaoqing Ai; Xiaojing Gu; Guangbiao Huang; Xue Li; Lijuan Pang; Minli Ding; Shuang Ding; Luxian Lv
Journal:  PLoS One       Date:  2015-10-08       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.